Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to boost motor skills in kids with brain development disorders

NCT ID NCT07323004

Knowledge-focused Sponsor: Aiyoudong Children and Youth Sports Health Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create a system to assess and improve motor skills in children aged 4 to 12 with neurodevelopmental disorders like ADHD. Researchers will test different exercise programs to see which ones best help these children move better and think more clearly. The goal is to catch delays early and provide effective interventions to support healthy development.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 4 to 12 years * Born at full term (gestational age ≥ 37 weeks and \< 42 weeks) * Provided informed consent signed by their legal guardian * For the ADHD group: * Diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) by a qualified physician (e.g., child psychiatrist or psychologist) according to DSM-5 diagnostic criteria * For the typical development (control) group: * No symptoms related to ADHD (e.g., inattention, hyperactivity, impulsivity) * Normal scores on parent- and teacher-rated behavioral questionnaires (e.g., CBCL, SDQ) * No history of neurological or psychiatric disorders Exclusion Criteria: * Diagnosis of other neurodevelopmental disorders, such as: * Autism Spectrum Disorder (ASD) * Learning disabilities * Epilepsy, cerebral palsy, or other neurological conditions * Developmental quotient (DQ) \< 85, as measured by standardized tools (e.g., Gesell scale) * Significant visual or hearing impairments, or congenital malformations * History of high-risk birth events, including but not limited to: * Severe birth asphyxia * Intrauterine infections * Presence of genetic or metabolic disorders, or severe dysfunction of vital organs * For the ADHD group: comorbid psychiatric conditions (e.g., schizophrenia, severe mood disorders)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyperactivity disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit-hyperactivity disorder neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurodevelopmental disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • China Institute of Sport Science

    Beijing, 100061, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.